Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 299
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT01104571 | Trastuzumab or Lapatinib Ditosylate in Treating Women With Early Breast Cancer | ||
| NCT06380816 | A Phase I/II Trial of UCB4594 in Participants With Advanced Cancer | ||
| NCT01937533 | Apparent Diffusion Coefficient as a Prognostic Biomarker in Cervical Cancer | ||
| NCT01324115 | NG-Nitro-L-Arginine in Treating Patients With Advanced Solid Tumors | ||
| NCT05057013 | A Phase I/IIa Trial of HMBD-001 in Advanced HER3 Positive Solid Tumours | ||
| NCT05722886 | DETERMINE (Determining Extended Therapeutic Indications for Existing Drugs in Rare Molecularly Defined Indications Using a National Evaluation Platform Trial) - Master Screening Protocol | ||
| NCT03145961 | A Trial Using ctDNA Blood Tests to Detect Cancer Cells After Standard Treatment to Trigger Additional Treatment in Early Stage Triple Negative Breast Cancer Patients | ||
| NCT03697239 | High Dose Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer | ||
| NCT02688257 | Assessing Treatment Response in Breast Cancer With Functional Imaging | ||
| NCT05361135 | 18-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in S. Aureus Bacteraemia | ||
| NCT01719835 | CHOP vs GEM-P in 1st Line Treatment of T-cell Lymphoma, Multicentre Phase II Study | ||
| NCT04478929 | Early Detection of Barrett's Esophagus Through Deep Image Retrieval | ||
| NCT03028766 | WEE1 Inhibitor with Cisplatin and Radiotherapy: a Trial in Head and Neck Cancer | ||
| NCT02077569 | AKT Inhibitor in Oestrogen Positive Breast Cancer | ||
| NCT01222221 | Vaccine Therapy, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme | ||
| NCT00554775 | WBRT & Erlotinib in Advanced NSCLC and Brain Metastases | ||
| NCT03432429 | Real Time Tissue Characterisation Using Mass Spectrometry REI-EXCISE iKnife Study | ||
| NCT00450203 | Chemotherapy With or Without Bevacizumab or Lapatinib to Treat Operable Oesophagogastric Cancer | ||
| NCT02024009 | Systemic Therapy and Chemoradiation in Advanced Localised Pancreatic Cancer - 2 | ||
| NCT05368298 | SCOOT: Sample Collection for DART | ||
| NCT00261456 | The IMPACT Study - Identification of Men With a Genetic Predisposition to ProstAte Cancer | ||
| NCT05848765 | Relapsed Follicular Lymphoma Randomised Trial Against Standard ChemoTherapy | ||
| NCT03415854 | Paclitaxel Protein Bound Plus Cisplatin Plus Gemcitabine and Paricalcitol for Pancreatic Adenocarcinoma (NABPLAGEMD) | ||
| NCT00985868 | AT9283 in Children and Adolescents With Relapsed and Refractory Solid Tumors | ||
| NCT07209774 | Healthspan Connect Programme of Research | ||
| NCT01331525 | The Addition of Ipilimumab to Carboplatin and Etoposide Chemotherapy for Extensive Stage Small Cell Lung Cancer | ||
| NCT01874171 | Determination of Cetuximab Versus Cisplatin Early and Late Toxicity Events in HPV+ OPSCC | ||
| NCT00006476 | Suramin in Treating Patients With Recurrent Bladder Cancer | ||
| NCT01810757 | Study of Weekly Radiotherapy for Bladder Cancer | ||
| NCT01132599 | Comparing PET-CT Using C-11 Choline and 18F-Fluoromethylcholine in Patients With Metastatic Prostate Cancer | ||
| NCT00757965 | Study of Genes and the Environment in Patients With Colorectal Cancer in the East Anglia Region of the United Kingdom | ||
| NCT02043899 | A Phase I/II Study of [124I]mIBG PET/CT in Neuroblastoma | ||
| NCT04161417 | Precision-Panc Master Protocol: Personalising Treatment for Pancreatic Cancer | ||
| NCT03562169 | The Role of Ixazomib in Autologous Stem Cell Transplant in Relapsed Myeloma - Myeloma XII (ACCoRd) | ||
| NCT05770037 | DETERMINE Trial Treatment Arm 01: Alectinib in Adult, Paediatric and Teenage/Young Adult Patients With ALK Positive Cancers | ||
| NCT00958854 | Fludarabine, Cyclophosphamide, and Thalidomide in Treating Patients With Angioimmunoblastic T-Cell Lymphoma | ||
| NCT02375204 | Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients with Relapsed or Refractory Germ Cell Tumors | ||
| NCT06289374 | Longitudinal Assessment of Biomarkers After Oesophagogastric Cancer Surgery | ||
| NCT05877352 | Intraoperative Electron Radiotherapy in Rectal Cancer - A Feasibility Trial | ||
| NCT00104897 | 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Metastatic Malignant Melanoma | ||
| NCT01147991 | Vaccine Therapy in Treating Patients With Epstein-Barr Virus-Related Cancer | ||
| NCT00900289 | Studying DNA in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer | ||
| NCT06045910 | A Phase I/II Trial of ALETA-001 for the Treatment of Participants With B-cell Malignancies | ||
| NCT00595777 | Edinburgh Pain Assessment Tool (EPAT©) Study | ||
| NCT03862911 | Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastatic (1-3 Metastases) Cancer | ||
| NCT00002476 | Radiation Therapy With or Without Chemotherapy in Treating Patients With Advanced Head and Neck Cancer | ||
| NCT03328247 | Achieving Self-directed Integrated Cancer Aftercare (ASICA) in Melanoma | ||
| NCT00641095 | Phase III, Multicentre, Randomised Study of Fludarabine/Cyclophosphamide Combination With or Without Rituximab in Patients With Untreated Mantle Cell Lymphoma | ||
| NCT00967954 | Study of Blood and Tissue Samples From Patients Receiving Androgen Deprivation for Newly Diagnosed Prostate Cancer | ||
| NCT02457156 | Cattell-Warren Versus Blumgart Techniques of Pancreatico-jejunostomy Following Pancreato-duodenectomy |
